Phase
Condition
Dementia
Mental Disability
Mild Cognitive Impairment
Treatment
N/AClinical Study ID
Ages 18-85 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
An adult between 18 and 85 years of age.
Has been evaluated to have a CDR (Clinical Dementia Rating) Score of 0.5
Male or female (if female must be postmenopausal for at least 1 year, surgicallysterile or using an effective form of contraception).
Able to speak and read English.
Willing to comply with study specific instructions, and complete all study proceduresaccording to protocol.
Able to understand study rationale and sign informed consent.
Exclusion
Exclusion Criteria:
Diagnosed with glaucoma
History of developing adverse effects to ophthalmic dilating agents (phenylephrine ortropicamide).
Currently taking warfarin and dabigatran (Pradaxa).
History of having arrhythmias - can interfere with EECP triggering.
Subject has bleeding diathesis.
Subject has active thrombophlebitis.
Subject has severe lower extremity vaso-occlusive disease.
Subject has a documented aortic aneurysm requiring surgical repair.
Subject is pregnant.
Subject with blood pressure higher than 180/110 mmHg.
Subject with a heart rate more than 120 bpm.
Subject with high risk of complications from increased venous return.
Subject with clinically significant valvular disease.
Subjects with severe vascular disease as established by the Hachinski Ischemic Index.
Subjects with pacemakers and other metallic implantable devices.
Study Design
Connect with a study center
University of Kansas Medical Center
Kansas City, Kansas 66160
United StatesSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.